Facebook Pixel

ExtendMy.Life may receive compensation if you choose to proceed via certain links or introductions, at no additional cost to you. Learn More

Longevytum – Longevity Clinic in Madrid, Spain

Large image for Longevytum – Longevity Clinic in Madrid, Spain

­Longevytum is a physician-led longevity and preventive medicine clinic based in Madrid, Spain.
The clinic operates within a diagnostics-first, Medicine 3.0 framework, focusing on early risk identification, long-term health planning, and system-level understanding of aging. This clinic does not position itself as a treatment center, retreat, or lifestyle brand.

It exists to measure, interpret, and monitor biological risk patterns so patients can make informed decisions in collaboration with their personal physicians

Clinic Overview

Longevytum operates as a medical unit specializing in predictive, preventive, and personalized longevity care. The clinic is designed to integrate efficiently into the schedules of executives, founders, and high-performers who value discretion, precision, and time efficiency.

At a Glance – Longevytum

Category

Details

Location

Madrid, Spain

Clinic Type

Physician-led longevity & preventive medicine clinic

Core Focus

Healthspan optimization & premature risk identification

Typical Stay

Short, structured clinical visits

Diagnostic Depth

Molecular, genetic, functional & imaging diagnostics

Signature Method

Medicine 3.0 with continuous monitoring

Environment

Clinical, private, non-spa setting

Privacy Level

GDPR-compliant, privacy-first workflows

Recognitions

Physician-led clinic with 2,500+ diagnostic assessments, 30+ years of physician experience, and professional recognition across European and Ibero-American longevity medicine societies

Many patients choose to arrive in Madrid a day early or extend their stay briefly after completing appointments at Longevytum. This allows for a controlled transition before returning to full professional demands, without requiring a dedicated recovery stay.

The map below highlights nearby premium hotels and serviced apartments commonly used for pre- or post-appointment stays.

Use the Quick Links below to navigate directly to the sections most relevant to your visit.

🔗 Quick Links

Purpose & Executive Profile

Clinical Purpose

The clinical purpose of Longevytum is to identify risk before disease, using advanced diagnostics to detect biological deterioration during its subclinical or silent phase.

Rather than focusing on treatment, the clinic supports:

  • Early risk identification
  • System-level understanding of aging
  • Long-term planning based on measurable data

Who This Clinic Is Designed For

Longevytum is designed for individuals who are:

  • Executives and senior decision-makers
  • Founders and entrepreneurs
  • Investors managing long planning horizons
  • Athletes and performance-driven professionals

The clinic is not intended for:

  • Acute medical care
  • Symptom-driven consultations
  • Wellness, spa, or retreat-style programs

🔍 Did You Know?

Studies of high-performing populations show that declines in sleep quality, energy, and cognitive stamina often appear years before formal diagnosis, acting as early biological warning signals rather than lifestyle inconveniences. (BMJ systematic review, 2016; NIH aging research).

Focus Areas Overview

Focus Area

What This Means in Practice

Medical Discipline

Preventive and predictive medicine

Core Biological Systems

Cardiovascular, metabolic, inflammatory, functional

Environment & Design

Clinical, discreet, non-spa setting

Program Structure

Tiered diagnostics with optional long-term monitoring

Lifestyle as Medicine

Evaluated as a clinical variable

Privacy

GDPR-compliant medical data governance

Long-Term Strategy

Ongoing reassessment across decades

Medical Philosophy – Medicine 3.0

Longevytum operates within a Medicine 3.0 framework, which shifts healthcare from reacting to disease toward anticipating and managing risk over time.

Unlike traditional models that focus on short-term (5–10 year) risk windows, Medicine 3.0 evaluates how biological systems degrade across decades. Physician interpretation is central—raw data alone is not considered actionable.

Core System Focus

Longevytum concentrates on biological systems most strongly associated with avoidable premature mortality:

  • Cardiovascular integrity
  • Metabolic regulation
  • Chronic inflammation
  • Physical and cognitive function

Lifestyle as a Medical Tool

Lifestyle factors—sleep duration, movement capacity, nutrition quality, and stress exposure—are assessed as measurable biological inputs, not wellness choices.

🔍 Did You Know?

 Sleeping less than seven hours per night is associated with a 12% increase in premature mortality risk, according to large population studies.

Advanced Diagnostics & Medical Assessment

Longevytum applies a diagnostics-first framework designed to identify biological risk during the silent phase of disease, when deterioration is measurable but symptoms are often absent.

The clinic combines molecular, genetic, functional, and imaging data to create a system-level risk profile. All findings are reviewed by physicians and presented as probabilistic risk indicators, not determinations of disease or treatment plans.

Diagnostic Assessment Includes

Diagnostic Domain

What Is Assessed

Biochemical & Molecular Markers

Cardiovascular risk, inflammation, metabolic and hormonal markers

Genetic & Hereditary Screening

Predisposition to cardiovascular and oncological conditions

Biological Age Measurement

Telomere length and omic-based aging markers

Functional & Biometric Testing

Muscle strength, flexibility, ergometry, mobility

Advanced Imaging

Coronary CT angiography (AngioTac), coronary calcium score, low-dose CT

Body Composition

Bone density, visceral fat, lean mass distribution

Chronomedicine & Future Risk Mapping

Longevytum applies a chronomedicine perspective, assessing how biological systems change over time rather than viewing health as a static snapshot. This approach allows clinicians to identify when risk acceleration may occur and where preventive planning may still be effective.

This model is especially relevant for individuals aged 35 and above, a period identified in longevity research as the point where biological decline begins to accelerate measurably.

🔍 Did You Know?

Recent research shows that genetics account for approximately 50% of longevity, with the remaining 50% influenced by environment, lifestyle, and modifiable biological factors (NIH longevity research; Nature Medicine epigenetic aging studies).

What the Clinic Does Best

Longevytum’s strength is not in offering treatments, but in structuring uncertainty.
The clinic specializes in identifying biological risk early, interpreting complex diagnostic signals, and maintaining longitudinal oversight as biology changes over time. Studies show that cardiorespiratory fitness declines by approximately 8–10% per decade after midlife (American College of Cardiology and longitudinal cohort studies), which is why longitudinal monitoring is emphasized over single-point evaluation.

Key Medical Strength 1: Silent Cardiovascular & Oncological Risk Detection

Longevytum focuses on identifying disease risk during its asymptomatic phase, when damage is accumulating but clinical signs are absent. The clinic applies advanced imaging and molecular analysis to detect arterial blockages, inflammatory burden, and early oncological indicators before they trigger events.

🔍 Did You Know?

Cardiovascular disease remains the leading cause of death globally, accounting for 18.6 million deaths in 2019 , while evidence suggests that up to 80% of premature cardiovascular mortality is potentially avoidable through early predictive diagnosis (Global Burden of Disease Study 2019; WHO epidemiology reports).

Key Medical Strength 2: Biological Age Measurement Over Chronological Age

Longevytum evaluates aging by measuring biological wear and tear, not years lived. Telomere analysis and molecular biomarkers are used to assess how quickly cellular systems are degrading relative to population norms.

Key Medical Strength 3: Functional Capacity as a Core Longevity Signal

The clinic treats physical autonomy as a measurable medical variable. Strength, mobility, and ergometric testing are used to confirm whether biological risk is translating into functional decline.

🔍 Did You Know?

 Individuals with low muscle strength face a 250% higher risk of all-cause mortality compared to those with higher strength, independent of age and other risk factors (Journal of Cachexia, Sarcopenia and Muscle meta-analysis).

Key Medical Strength 4: Longitudinal Monitoring Through the Active Aging Plan

Longevytum’s model is designed for continuous reassessment, not one-time evaluation. Periodic testing allows physicians to track changes in biological markers over time and detect risk acceleration early. This longitudinal approach reflects the reality that aging is dynamic, not static. Additionally, targeted preemptive action has been shown to extend disease-free life and reduce late-life chronic illness by up to 10 years, according to systems medicine research (systems medicine and preventive aging research; NEJM reviews)..

Key Medical Strength 5: Precision Imaging for Subclinical Disease

Advanced non-invasive imaging tools, including coronary CT angiography and calcium scoring, are used to identify structural changes that traditional blood tests cannot detect.

This enables risk identification at a stage where intervention decisions remain open.

🔍 Did You Know?

Elevated Lipoprotein(a)—a key genetic driver of atherosclerosis—affects 8% to 20% of the population, often without outward symptoms or early warning signs (Journal of the American College of Cardiology consensus studies).

Executive Outcomes

Longevytum documents outcomes in terms of risk awareness, decision clarity, and planning confidence, not cures or performance guarantees. The following summaries reflect patterns reported in clinic-published materials and patient testimonials.

Outcome 1 – From Uncertainty to Structured Risk Awareness

Before:
Limited visibility into silent cardiovascular, metabolic, or inflammatory risk. Standard checkups indicated values “within range,” offering reassurance but little long-term insight.

After:
Clear identification of biological risk patterns using molecular markers, functional testing, and precision imaging—allowing informed discussions with personal physicians.

Source:
Longevytum patient-reported experiences and clinical summaries.

🔍 Did You Know?

Clinical evidence shows that many cardiovascular and oncological diseases develop silently for years, with symptoms often appearing only after significant biological damage has occurred.

Population-level studies show that just 90 minutes of moderate exercise per week is associated with a 14% reduction in all-cause mortality, reinforcing why functional capacity is assessed as a medical variable rather than a lifestyle preference (large prospective cohort studies; WHO physical activity analyses).

Signature Longevity & Medical Programs

Longevytum offers tiered diagnostic programs aligned with different levels of risk assessment and monitoring depth.

Programs are designed for evaluation and monitoring, not treatment.

Program Overview

Program Tier

Diagnostic Scope

Intended Purpose

Standard Aging Study

Molecular biomarkers, functional testing, biological age

Baseline longevity and risk assessment

Aging Plus Study

Adds hereditary cancer risk screening

Expanded risk mapping

Advanced Aging Study

Includes precision cardiovascular imaging

Comprehensive long-term risk profiling

Active Aging Plan

Periodic reassessment over time

Longitudinal monitoring

Therapies, Facilities & Clinical Environment

Longevytum is structured as a medical unit, not a treatment center or wellness space. Its environment, facilities, and supportive therapies exist to enable accurate diagnostics, preserve functional capacity, and support long-term monitoring, rather than to deliver restorative experiences.

All services operate within a physician-led, diagnostics-first framework.

Medical & Supportive Therapies

Therapies at Longevytum are positioned as supportive clinical services to maintain function, mobility, and physiological stability as part of a broader longevity strategy.

These may include:

  • Physician-supervised preventive protocols
  • Physiotherapy focused on mobility and musculoskeletal resilience
  • Functional rehabilitation assessments
  • Pelvic floor and posture-focused evaluations where relevant

Therapies are not presented as treatments or cures, but as adjuncts to risk management and functional preservation.

🔍 Did You Know?

Pelvic floor dysfunction affects nearly 1 in 3 women, making it one of the most common—and often underdiagnosed—functional health issues in adult populations.

Clinical Facilities

Longevytum’s facilities support deep diagnostic precision, enabling physicians to identify risk patterns that are not detectable through standard checkups.

Key clinical infrastructure includes:

  • Advanced molecular and biochemical analysis labs
  • Precision imaging access (including coronary CT angiography and calcium scoring)
  • Genetic and hereditary risk assessment tools
  • Functional and ergometric testing areas
  • Body composition and bone density (DEXA) scanning

🔍 Did You Know?

For adults aged 65 and older, suffering a hip fracture is associated with a 30–40% mortality risk within one year, underscoring the importance of early functional and bone health assessment.

Architecture, Environment & Digital Discipline

The clinic environment is intentionally clinical, discreet, and efficiency-oriented. Design choices prioritize accuracy, privacy, and time discipline rather than sensory stimulation.

Key characteristics include:

  • Quiet consultation spaces for physician interpretation
  • Minimal waiting time and structured scheduling
  • Strong data protection and GDPR-compliant workflows
  • Controlled digital environments to reduce distraction

🔍 Did You Know?

Among individuals aged 95 and older in certain Spanish regions, chronic arterial hypertension affects more than 85%, yet many maintain cognitive and functional autonomy—highlighting the role of monitoring and management rather than diagnosis alone.

Pricing, Program Structure & Length of Stay

Longevytum presents pricing and program design as a function of diagnostic depth and longitudinal oversight, not therapeutic intensity. Costs reflect the scope of medical assessment, imaging access, physician interpretation time, and follow-up structure rather than amenities or experiential elements.

Pricing 

Category

Details

Clinic Positioning

Physician-led, diagnostics-first medical unit

Stay Length

Short, structured clinical visits

Entry Pricing

Indicative mid-to-high four-figure range

What’s Included

Diagnostics, physician interpretation, reporting

Additional Costs

Dependent on imaging and genetic scope

Program Structure

Tiered assessment with optional long-term monitoring

Clinical Principle

Precision, not volume

How Programs Are Structured

Longevytum programs follow a standardized medical workflow designed to maximize diagnostic clarity while minimizing time burden for high-performers.

Typical flow includes:

  1. Pre-visit preparation
    Review of health history, previous data, and planning objectives.
  2. On-site diagnostics
    Biomarkers, functional testing, and imaging as applicable.
  3. Physician interpretation
    Integration of findings into a system-level risk overview.
  4. Reporting
    Structured documentation positioned for review with a personal physician.

🔍 Did You Know?

Comparative research shows that individuals transitioning from a fully sedentary lifestyle to approximately 15 MET-hours per week (roughly three one-hour brisk walks) experience up to a 50% reduction in Alzheimer’s disease risk (Alzheimer’s Association epidemiological studies).

Length of Stay

Longevytum is designed for efficiency rather than residency. Most diagnostic assessments are completed over short, planned visits, allowing integration into existing professional schedules.

Extended stays are not required for program completion, though some individuals choose additional time in Madrid for scheduling flexibility or post-assessment transition.

Plan Your Stay at Longevytum

Longevytum is designed to integrate into existing professional schedules rather than requiring extended time away from work. Most visitors plan their stay around diagnostic appointments, with flexibility to arrive shortly before or depart shortly after assessments.

The clinic does not operate as a residential facility. Stay planning is handled independently and is typically aligned with business travel or short personal visits.

Accommodation & Stay Planning

Longevytum does not provide on-site accommodation. Patients typically stay in nearby premium hotels or serviced apartments, selecting locations that support privacy, walkability, and efficient travel to the clinic.

🔗 Explore nearby hotels & apartments

🔍 Did You Know?

Spain is projected to reach approximately 100,000 centenarians by 2050, highlighting why long-term health planning is increasingly relevant for mid-career professionals (Instituto Nacional de Estadística population projections).

How to Reach the Clinic

  • Nearest Airport: Madrid–Barajas Adolfo Suárez Airport
  • Access: Taxi, private transfer, or ride-hailing services
  • Urban Connectivity: Well-connected via Madrid’s road and public transport network

🔗 Find best flights to Madrid
🔗 Find car rentals in Madrid

What to Bring

  • Relevant prior medical reports or imaging (if available)
  • Comfortable clothing suitable for functional assessments
  • Any required identification or documentation requested in advance

No specialized equipment or extended preparation is typically required

Outcomes & Reputation

Longevytum’s reputation is built around diagnostic clarity, physician interpretation, and long-term oversight rather than short-term results. Reported outcomes focus on understanding risk, improving planning confidence, and establishing a structured health framework that can be revisited over time.

What Patients Commonly Report

Across clinic-published materials and verified testimonials, recurring themes include:

  • Clear explanation of complex diagnostic findings
  • Greater visibility into silent or subclinical risk patterns
  • Confidence in discussing results with a personal physician
  • Appreciation for a calm, non-urgent clinical tone
  • Perception of the process as a long-term investment rather than a one-time intervention

🔍 Did You Know?

Large population studies show that individuals with low VO₂ max have up to a 400% higher risk of all-cause mortality compared to those in the top fitness percentile—supporting why functional capacity is treated as a core diagnostic signal (cardiorespiratory fitness cohort studies; JACC analyses).

Media & Professional Recognition

Longevytum’s clinical approach and public communication have been recognized across medical, business, and mainstream media channels. Coverage typically highlights the clinic’s focus on preventive longevity, biological age assessment, and the shift toward predictive medicine.

Professional credibility is reinforced through:

  • Leadership by a physician with over 30 years of experience in national health system protocols
  • Membership in European, Spanish, and Ibero-American scientific societies focused on longevity and age management
  • Quality certification aligned with Madrid regional health standards
  • A documented history of 2,500+ patient engagements

Media references and institutional affiliations are presented to support transparency and editorial trust, not endorsement.

How to Think About Longevytum

Longevytum is best understood as a diagnostics-first medical reference point, not a treatment provider or wellness destination.

The clinic’s purpose is to clarify long-term biological risk while options remain open. By combining advanced diagnostics with physician interpretation, it helps individuals understand how aging is progressing at a system level—often before conventional care surfaces any concern.

For executives and high-performers, the value lies in clarity without urgency. Longevytum supports informed, forward-looking health decisions without positioning itself as the decision-maker or solution.

Frequently Asked Questions

Is Longevytum a medical clinic or a wellness center?

Longevytum operates as a physician-led medical clinic focused on diagnostics, risk assessment, and long-term health planning. It does not function as a wellness center, spa, or retreat, and it does not offer experiential or lifestyle-based programs.

How personalised is the assessment?

Assessments are personalised through diagnostic interpretation, not through bespoke treatment plans. Diagnostic scope, imaging depth, and monitoring cadence are adapted to individual risk profiles and objectives, while medical decisions remain the responsibility of the patient and their personal physician.

Does the clinic provide medical treatment or prescriptions?

Longevytum focuses on assessment, interpretation, and monitoring. It does not position itself as a treatment provider, and it does not replace a patient’s primary healthcare team. Any medical decisions or interventions must be discussed with a personal physician.

How is privacy and data protection handled?

All medical data is handled under GDPR-compliant medical governance. Information is processed solely for clinical purposes, with patient consent, and is not shared with third parties except where legally required.

Can I stay connected and work during my visit?

Yes. The clinic is structured for professionals who remain operational during visits. Appointments are scheduled efficiently, and there are no digital restrictions imposed outside of consultation settings.

Is this clinic suitable for people with diabetes or chronic conditions?

Longevytum does not provide treatment for chronic conditions. However, individuals with existing diagnoses may use diagnostic assessments to better understand risk patterns and progression, in coordination with their treating physician.

How should value be evaluated relative to cost?

Value is best assessed in terms of:

  • Diagnostic depth
  • Physician interpretation time
  • Long-term relevance of findings
  • Clarity gained for future decision-making

The clinic’s services are positioned as strategic health intelligence, not short-term care.

A Strategic Pause That Protects the Years Ahead

Longevity planning is no longer a speculative interest or a lifestyle trend. For executives, founders, and high-performers, it has become a matter of risk management over time—the disciplined evaluation of factors that may influence cognitive capacity, physical autonomy, and decision-making decades into the future.

Longevytum exists for individuals who recognise that the most consequential health risks rarely announce themselves early. Cardiovascular disease, metabolic dysfunction, and systemic decline often develop quietly, long before they interfere with daily performance. By the time symptoms appear, options are narrower and decisions more constrained.

The clinic’s role is not to intervene, promise improvement, or replace primary care. Its purpose is to make uncertainty legible—to translate complex biological data into structured insight that can inform long-term planning. This includes understanding how biological age compares to chronological age, where functional capacity may be trending, and which risk factors merit closer attention over time.

For high-performers accustomed to managing financial, operational, and strategic exposure, this approach mirrors familiar decision frameworks. Information is gathered early. Interpretation is handled by specialists. Action remains deliberate, proportional, and personal.

Choosing to engage with a diagnostics-first longevity clinic is not an urgent decision. It is a measured one—a pause taken early enough to preserve optionality later. For those thinking in decades rather than quarters, that pause can shape how the years ahead are navigated.

 ↩ Return to ExtendMy.Life
  ⬆ Back to Top

Disclaimer

This page is provided for informational and editorial purposes only. It does not constitute medical advice, diagnosis, or treatment, and should not be relied upon as a substitute for consultation with a qualified healthcare professional. No doctor–patient relationship is established through the use of this content. All diagnostic assessments described indicate risk probability, not certainty, and individual outcomes may vary based on genetics, lifestyle, medical history, and external factors. Longevytum does not provide guarantees regarding health outcomes, disease prevention, or performance improvement. Any medical decisions, treatments, or interventions must be made in consultation with a personal physician or licensed medical provider who is familiar with the individual’s full medical history. All information is presented in accordance with applicable medical governance and data protection standards. References to diagnostics, programs, or methodologies are descriptive only and do not imply suitability for any specific individual.

References

Alzheimer’s Association (2023) Physical activity, exercise and Alzheimer’s disease.

British Medical Journal (BMJ) (2016) ‘Sleep duration and mortality: a systematic review and meta-analysis’, BMJ, 355, i5210.

European Medicines Agency (EMA) (2022) Guidance on clinical investigations and diagnostics.

European Society of Cardiology (ESC) (2021) ‘Guidelines on cardiovascular disease prevention in clinical practice’, European Heart Journal, 42(34), pp. 3227–3337.

Instituto Nacional de Estadística (INE) (2023) Population structure and centenarian statistics in Spain.

Journal of Cachexia, Sarcopenia and Muscle (2018) ‘Muscle strength and mortality risk in older adults’, Journal of Cachexia, Sarcopenia and Muscle, 9(1), pp. 3–18.

Journal of the American College of Cardiology (JACC) (2018) ‘Coronary artery calcium scoring and cardiovascular risk prediction’, Journal of the American College of Cardiology, 72(4), pp. 434–447.

National Institute on Aging (2022) Biology of aging and longevity research.

Nature Medicine (2018) ‘An epigenetic biomarker of aging for lifespan and healthspan’, Nature Medicine, 24(4), pp. 529–538.

New England Journal of Medicine (NEJM) (2015) ‘Preventive medicine and the aging population’, New England Journal of Medicine, 373(22), pp. 2093–2096.

The Lancet (2019) ‘Global burden of cardiovascular disease’, The Lancet, 393(10191), pp. 1983–1992.

World Health Organization (WHO) (2023) Cardiovascular diseases (CVDs): Fact sheet.

Share: